Dr Alberto Sergio Aleotti, Director of Menarini Group, dies aged 92

8 May 2014

Italian pharmaceutical company Menarini Group has announced that previous manager Dr Alberto Sergio Aleotti has passed away. Since joining Menarini in 1964, Dr Aleotti had recently handed over management of the Group to his children, Lucia, Chairman, and Alberto Giovanni, Vice Chairman.

Dr Aleotti was born on 4 March 1923 in the Province of Reggio Emilia, Italy. In 1946, he was awarded a BSc Degree in Economics and Business Studies from the University of Bologna.

During the 1970s and 80s Dr Aleotti held office as President of Farmunione, the Italian association of small and medium enterprises. During this timehe was appointed Knight of Labour by the then President of the Republic, Sandro Pertini. In 1986 he was summoned to act as Vice President of the European Federation of Pharmaceutical Industries and Associations (EFPIA). From 1990 to 1992 he was appointed Vice President of the International Federation of Pharmaceutical Manufacturers Associations (IFPMA).

In his lifetime Dr Aleotti was awarded an Honorary Degree in Chemistry and Pharmaceutical Technology from the Faculty of Pharmacology at the University of Genoa, the first honorary degree awarded by the Faculty in over one hundred years of the University’s history. On the recommendation of the Federal Chancellor, the President of the Federal Republic of Germany awarded him the Grosses Verdienstkreuz (Cross for Merit) for the economic and social contribution made to Germany through the reorganisation of Berlin-Chemie, purchased by Menarini in 1992. In 2007 he received the Ernst & Young “Best Entrepreneur of the Year” Award in the Global category.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical